Scilex Holding SCLX 深 沪
等待开盘 10-01 09:30:00 美东时间
19.68
-6.940
-26.07%
华盛通- 最 高26.99
- 今 开26.72
- 成交量 56.86万股
- 最 低 19.10
- 昨 收 26.62
- 总市值 1.08亿
- 52周最高 39.90
- 市盈率 静 --
- 换手率 10.34%
- 52周最低 3.60
- 委 比 84.59%
- 总股本 549.74万
- 历史最高 591.50
- 量 比 1.98
- 振 幅 29.64%
- 历史最低 0.00
- 每 手 1
- 风险率 9.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Datavault And New Era Energy: AI Penny Stock Powerhouses
Datavault AI, Inc. (NASDAQ: DVLT) and New Era Energy & Digital, Inc. (NASDAQ: NUAI) were tearing up the
09-26 22:49
Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI
Scilex Holding Company (Nasdaq: SCLX) has completed the initial tranche of its $150 million Bitcoin investment in Datavault AI Inc. (Nasdaq: DVLT), receiving 15 million shares of Datavault common stock. The remaining shares are subject to shareholder approval. Scilex, focused on non-opioid pain management and neurodegenerative disease treatments, has commercial products like ZTlido®, ELYXYB®, and Gloperba®, and is developing SP-102, SP-103, and S...
09-26 19:57
每日数字货币动态汇总（2025-09-26）
小程序：每日数字货币动态汇总 1. 花旗上调稳定币预测：2030年规模或达4万亿美元，但银行代币潜力更大 花旗银行发布最新报告，将2030年全球稳定币发行量预测...
09-26 10:48
Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI
Scilex Holding Company announced a $150 million Bitcoin investment in Datavault AI Inc. to expand its supercomputing infrastructure and unlock new revenue streams. The deal aims to leverage Datavault's AI and blockchain technology to capture growth in biotech data monetization. Scilex will receive up to 278.9 million shares, with rights to nominate directors based on ownership. The partnership highlights Scilex's expertise in biotech and Datavaul...
09-25 19:45
Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management
Scilex Holding Company, a company specializing in non-opioid pain management products, has signed a non-binding Memorandum of Understanding (MOU) with Biconomy.com to collaborate on cryptocurrency and treasury management strategies. The partnership aims to enhance Scilex’s digital asset trading and management, leveraging Biconomy’s platform for global cryptocurrency services, establishing a secure and compliant treasury strategy, and utilizing Bi...
09-24 14:11
Scilex To Exchange $200M In Semnur Stock For $200M In Bitcoin Under Securities Purchase Agreement With Institutional Investor
Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of
09-23 22:02
Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin
Scilex Holding Company has signed a Securities Purchase Agreement with an institutional investor to exchange $200 million of Semnur Pharmaceuticals' common stock for $200 million in Bitcoin. The deal involves the purchase of 12.5 million Semnur shares at $16 per share, subject to customary closing conditions and expected to close by September 23, 2025. The transaction qualifies under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regula...
09-23 14:00
Semnur Pharmaceuticals, A Majority-Owned Subsidiary Of Scilex Holding Company Announces That Shareholders Of Denali Capital Acquisition Corp Have Approved The Previously Announced Business Combination With Semnur; Financial Terms Not Disclosed
Semnur Pharmaceuticals, Inc. ("Semnur"), a majority-owned subsidiary of Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and
09-04 21:05
Scilex CEO to resign as focus turns to Semnur – Denali merger
Scilex Holding (NASDAQ:SCLX) announced on Thursday that its CEO, Jaisim Shah, would resign and continue to lead its majority-owned subsidiary Semnur Pharmaceuticals, which has signed a merger agreemen...
08-21 18:57
Scilex Holding Q2 EPS $(7.42) Misses $(0.91) Estimate, Sales $9.896M Miss $26.250M Estimate
Scilex Holding (NASDAQ:SCLX) reported quarterly losses of $(7.42) per share which missed the analyst consensus estimate of $(0.91) by 715.38 percent. This is a 31.61 percent increase over losses of $(10.85) per share
08-14 15:42
